Susquehanna International Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.4M | Sell |
297,300
-394,800
| -57% | -$60.5M | 0.01% | 1368 |
|
|
2025
Q4 | $95.4M | Buy |
692,100
+126,300
| +22% | +$16.5M | 0.01% | 918 |
|
|
2025
Q3 | $72.6M | Sell |
565,800
-226,100
| -29% | -$27.6M | 0.01% | 1093 |
|
|
2025
Q2 | $95.8M | Buy |
791,900
+300,100
| +61% | +$33.8M | 0.01% | 779 |
|
|
2025
Q1 | $54.8M | Sell |
491,800
-47,900
| -9% | -$5.1M | 0.01% | 974 |
|
|
2024
Q4 | $52.5M | Buy |
539,700
+258,200
| +92% | +$27.5M | 0.01% | 1083 |
|
|
2024
Q3 | $32.4M | Sell |
281,500
-197,000
| -41% | -$22.4M | 0.01% | 1410 |
|
|
2024
Q2 | $50.9M | Buy |
478,500
+227,500
| +91% | +$22.8M | 0.01% | 975 |
|
|
2024
Q1 | $24.3M | Sell |
251,000
-58,400
| -19% | -$5.99M | ﹤0.01% | 1589 |
|
|
2023
Q4 | $31.2M | Sell |
309,400
-47,900
| -13% | -$4.62M | 0.01% | 1378 |
|
|
2023
Q3 | $36.4M | Sell |
357,300
-107,400
| -23% | -$10.9M | 0.01% | 1235 |
|
|
2023
Q2 | $46.9M | Buy |
464,700
+30,700
| +7% | +$3.07M | 0.01% | 1045 |
|
|
2023
Q1 | $39.9M | Sell |
434,000
-423,400
| -49% | -$37M | 0.01% | 1095 |
|
|
2022
Q4 | $77.8M | Buy |
857,400
+168,300
| +24% | +$14.2M | 0.02% | 663 |
|
|
2022
Q3 | $52.4M | Sell |
689,100
-76,900
| -10% | -$6.37M | 0.01% | 776 |
|
|
2022
Q2 | $64.8M | Sell |
766,000
-340,800
| -31% | -$29.9M | 0.02% | 715 |
|
|
2022
Q1 | $97.1M | Sell |
1,106,800
-33,200
| -3% | -$2.87M | 0.02% | 670 |
|
|
2021
Q4 | $99.7M | Buy |
1,140,000
+299,000
| +36% | +$24.8M | 0.02% | 711 |
|
|
2021
Q3 | $68.8M | Buy |
841,000
+105,200
| +14% | +$9.46M | 0.01% | 968 |
|
|
2021
Q2 | $67.1M | Sell |
735,800
-21,700
| -3% | -$1.93M | 0.01% | 996 |
|
|
2021
Q1 | $64.8M | Sell |
757,500
-212,700
| -22% | -$19.1M | 0.01% | 941 |
|
|
2020
Q4 | $91.6M | Buy |
970,200
+162,300
| +20% | +$14.2M | 0.02% | 692 |
|
|
2020
Q3 | $70.3M | Buy |
807,900
+82,100
| +11% | +$7.11M | 0.01% | 705 |
|
|
2020
Q2 | $63.4M | Buy |
725,800
+118,300
| +19% | +$10.2M | 0.02% | 699 |
|
|
2020
Q1 | $50.1M | Buy |
607,500
+43,800
| +8% | +$3.91M | 0.02% | 656 |
|
|
2019
Q4 | $53.4M | Buy |
563,700
+73,100
| +15% | +$6.56M | 0.02% | 777 |
|
|
2019
Q3 | $42.6M | Sell |
490,600
-201,600
| -29% | -$18.1M | 0.01% | 832 |
|
|
2019
Q2 | $63.2M | Buy |
692,200
+57,419
| +9% | +$4.86M | 0.02% | 582 |
|
|
2019
Q1 | $54.7M | Buy |
634,781
+104,569
| +20% | +$8.39M | 0.02% | 581 |
|
|
2018
Q4 | $40.8M | Buy |
530,212
+196,751
| +59% | +$15.3M | 0.02% | 684 |
|
|
2018
Q3 | $25.7M | Sell |
333,461
-105,239
| -24% | -$7.78M | 0.01% | 1135 |
|
|
2018
Q2 | $29.7M | Sell |
438,700
-172,868
| -28% | -$11.9M | 0.01% | 998 |
|
|
2018
Q1 | $44.3M | Buy |
611,568
+340,268
| +125% | +$25.9M | 0.02% | 715 |
|
|
2017
Q4 | $20.4M | Buy |
271,300
+171,864
| +173% | +$13M | 0.01% | 1233 |
|
|
2017
Q3 | $7.65M | Sell |
99,436
-195,858
| -66% | -$14.8M | ﹤0.01% | 2039 |
|
|
2017
Q2 | $22.1M | Buy |
295,294
+95,865
| +48% | +$6.79M | 0.01% | 1091 |
|
|
2017
Q1 | $13.3M | Sell |
199,429
-41,515
| -17% | -$2.77M | 0.01% | 1373 |
|
|
2016
Q4 | $15.7M | Sell |
240,944
-28,235
| -10% | -$1.83M | 0.01% | 1220 |
|
|
2016
Q3 | $19M | Sell |
269,179
-62,831
| -19% | -$4.58M | 0.01% | 1049 |
|
|
2016
Q2 | $24.5M | Buy |
332,010
+76,669
| +30% | +$5.3M | 0.01% | 857 |
|
|
2016
Q1 | $16.6M | Buy |
255,341
+37,051
| +17% | +$2.52M | 0.01% | 1121 |
|
|
2015
Q4 | $16.8M | Sell |
218,290
-95,306
| -30% | -$7.57M | 0.01% | 1269 |
|
|
2015
Q3 | $25.8M | Sell |
313,596
-179,564
| -36% | -$16M | 0.01% | 1015 |
|
|
2015
Q2 | $43.5M | Buy |
493,160
+268,063
| +119% | +$24.6M | 0.02% | 760 |
|
|
2015
Q1 | $19.9M | Buy |
225,097
+151,553
| +206% | +$13.4M | 0.01% | 1242 |
|
|
2014
Q4 | $6.11M | Sell |
73,544
-18,972
| -21% | -$1.57M | ﹤0.01% | 2615 |
|
|
2014
Q3 | $7.8M | Sell |
92,516
-217,844
| -70% | -$17.6M | ﹤0.01% | 2411 |
|
|
2014
Q2 | $25.2M | Sell |
310,360
-201,438
| -39% | -$15.8M | 0.01% | 1188 |
|
|
2014
Q1 | $39M | Sell |
511,798
-347,187
| -40% | -$25.3M | 0.02% | 782 |
|
|
2013
Q4 | $61.9M | Buy |
858,985
+442,940
| +106% | +$30.8M | 0.03% | 548 |
|
|
2013
Q3 | $28.6M | Sell |
416,045
-35,823
| -8% | -$2.37M | 0.02% | 946 |
|
|
2013
Q2 | $28.6M | Buy |
+451,868
| New | +$29.4M | 0.02% | 853 |
|
Other funds holding NVS
Susquehanna International Group's NVS Position: Q1 2026 in Review
Susquehanna International Group reduced its Novartis (NVS) stake by 37% in Q1 2026, selling an estimated $5.41M and leaving 60,281 shares worth $9.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3238.
Susquehanna International Group first reported a position in NVS in Q2 2013 and has held it in 34 quarters since. The position peaked at $32.2M in Q4 2024. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Susquehanna International Group held 60,281 shares of Novartis worth $9.21M as of Q1 2026.
- Susquehanna International Group sold 35,284 Novartis shares in Q1 2026, an estimated $5.41M.
- Novartis made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3238 holding.
- Susquehanna International Group first reported a position in Novartis in Q2 2013 and has held it in 34 quarters since.
- Susquehanna International Group's Novartis position peaked at $32.2M in Q4 2024.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.